{"id":"W2094704437","doi":"10.1007/s00280-007-0442-7","title":"O6-benzylguanine and BCNU in multiple myeloma: a phase II trial","year":2007,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Carmustine; Medicine; Multiple myeloma; Neutropenia; Internal medicine; Chemotherapy; Bone marrow; Toxicity; Oncology; Gastroenterology; Regimen; Pharmacology; Etoposide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027492,0.0001748871,0.0003513217,0.0001608797,0.0001103816,0.000007327104,0.00004566823,0.0001178557,0.001079107],"category_scores_gemma":[0.00002040506,0.0001462116,0.00003993156,0.0001717142,0.0001672982,0.00005738765,0.00003480934,0.0002323703,0.00000265745],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009324704,"about_ca_system_score_gemma":0.00009497362,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001418011,"about_ca_topic_score_gemma":0.000160454,"domain_scores_codex":[0.9988361,0.00003965825,0.0002390436,0.0003255467,0.0001196024,0.0004400697],"domain_scores_gemma":[0.9993699,0.0001578393,0.00005115187,0.00008938997,0.0000384591,0.0002932564],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2128733,0.002392398,0.03005278,0.0001180307,0.0003671024,0.0004541223,0.001296541,6.719004e-7,0.3077685,0.00002042891,0.002086388,0.4425697],"study_design_scores_gemma":[0.6668898,0.005573468,0.02132101,0.00004436986,0.00009552814,0.00007582242,0.0001010767,0.001081441,0.2485386,0.00005967604,0.05596977,0.0002495139],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918522,0.004318305,0.0000389119,0.002027455,0.0002516562,0.001065398,0.00002004093,0.00002969513,0.0003963872],"genre_scores_gemma":[0.9923513,0.003754067,0.000215105,0.002348157,0.0005303545,0.0001288209,0.00001714719,0.00002239672,0.0006326718],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4540164,"threshold_uncertainty_score":0.9998341,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04729938861380173,"score_gpt":0.412195691664822,"score_spread":0.3648963030510203,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}